Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:2570359rdf:typepubmed:Citationlld:pubmed
pubmed-article:2570359lifeskim:mentionsumls-concept:C0020731lld:lifeskim
pubmed-article:2570359lifeskim:mentionsumls-concept:C0034493lld:lifeskim
pubmed-article:2570359lifeskim:mentionsumls-concept:C0034052lld:lifeskim
pubmed-article:2570359lifeskim:mentionsumls-concept:C0205102lld:lifeskim
pubmed-article:2570359lifeskim:mentionsumls-concept:C0243192lld:lifeskim
pubmed-article:2570359lifeskim:mentionsumls-concept:C0015101lld:lifeskim
pubmed-article:2570359lifeskim:mentionsumls-concept:C0021467lld:lifeskim
pubmed-article:2570359lifeskim:mentionsumls-concept:C2825032lld:lifeskim
pubmed-article:2570359lifeskim:mentionsumls-concept:C2003941lld:lifeskim
pubmed-article:2570359lifeskim:mentionsumls-concept:C0021469lld:lifeskim
pubmed-article:2570359lifeskim:mentionsumls-concept:C0596235lld:lifeskim
pubmed-article:2570359lifeskim:mentionsumls-concept:C0851827lld:lifeskim
pubmed-article:2570359lifeskim:mentionsumls-concept:C1701901lld:lifeskim
pubmed-article:2570359lifeskim:mentionsumls-concept:C1140999lld:lifeskim
pubmed-article:2570359pubmed:issue5lld:pubmed
pubmed-article:2570359pubmed:dateCreated1989-9-29lld:pubmed
pubmed-article:2570359pubmed:abstractTextContractions were induced in rings of rabbit pulmonary artery with the preferential alpha 1-adrenoceptor agonists, phenylephrine, methoxamine and St 587 [2-(2-chloro-trifluoromethyl-phenylimino)imidazolidine and the preferential alpha 2-adrenoceptor agonists, clonidine and B-HT 920 [6-allyl-2-amino-5,6,7,8-tetrahydro-4H-thiazolo-(4,5-d) azepine] [corrected]. Phenylephrine and methoxamine acted as full agonists whereas St 587, clonidine and B-HT 920 were partial agonists (intrinsic activities 0.62, 0.38 and 0.42, respectively). Experiments with alpha 1- and alpha 2-adrenoceptor antagonists indicated that the receptors involved are of the alpha 1 type only. Removal of extracellular Ca2+ inhibited maximal contractions to phenylephrine and methoxamine by 30% and 49%, respectively. The remaining contraction components of the full agonists were abolished by the "intracellular Ca2+ antagonist" TMB-8 [8-(N,N-diethylamino)octyl-3,4,5-trimethoxybenzoate]. Contractions to St 587, clonidine and B-HT 920 were virtually abolished in Ca2+-free medium. Pretreatment of the donor rabbits with pertussis toxin (2.5 micrograms/kg i.v., 5-6 days before sacrifice) attenuated the efficacies of the full agonists, phenylephrine and methoxamine by only 24% and 17%, respectively, whereas maximal contractions to the partial agonists, St 587, clonidine and B-HT 920, were inhibited by 46%, 61% and 75%, respectively.(ABSTRACT TRUNCATED AT 250 WORDS)lld:pubmed
pubmed-article:2570359pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2570359pubmed:languageenglld:pubmed
pubmed-article:2570359pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2570359pubmed:citationSubsetIMlld:pubmed
pubmed-article:2570359pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2570359pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2570359pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2570359pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2570359pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2570359pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2570359pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2570359pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2570359pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2570359pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2570359pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2570359pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2570359pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2570359pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2570359pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2570359pubmed:statusMEDLINElld:pubmed
pubmed-article:2570359pubmed:monthMaylld:pubmed
pubmed-article:2570359pubmed:issn0028-1298lld:pubmed
pubmed-article:2570359pubmed:authorpubmed-author:FörstermannUUlld:pubmed
pubmed-article:2570359pubmed:authorpubmed-author:LiebauSSlld:pubmed
pubmed-article:2570359pubmed:authorpubmed-author:HohlfeldJJlld:pubmed
pubmed-article:2570359pubmed:issnTypePrintlld:pubmed
pubmed-article:2570359pubmed:volume339lld:pubmed
pubmed-article:2570359pubmed:ownerNLMlld:pubmed
pubmed-article:2570359pubmed:authorsCompleteYlld:pubmed
pubmed-article:2570359pubmed:pagination496-502lld:pubmed
pubmed-article:2570359pubmed:dateRevised2008-11-21lld:pubmed
pubmed-article:2570359pubmed:meshHeadingpubmed-meshheading:2570359-...lld:pubmed
pubmed-article:2570359pubmed:meshHeadingpubmed-meshheading:2570359-...lld:pubmed
pubmed-article:2570359pubmed:meshHeadingpubmed-meshheading:2570359-...lld:pubmed
pubmed-article:2570359pubmed:meshHeadingpubmed-meshheading:2570359-...lld:pubmed
pubmed-article:2570359pubmed:meshHeadingpubmed-meshheading:2570359-...lld:pubmed
pubmed-article:2570359pubmed:meshHeadingpubmed-meshheading:2570359-...lld:pubmed
pubmed-article:2570359pubmed:meshHeadingpubmed-meshheading:2570359-...lld:pubmed
pubmed-article:2570359pubmed:meshHeadingpubmed-meshheading:2570359-...lld:pubmed
pubmed-article:2570359pubmed:meshHeadingpubmed-meshheading:2570359-...lld:pubmed
pubmed-article:2570359pubmed:meshHeadingpubmed-meshheading:2570359-...lld:pubmed
pubmed-article:2570359pubmed:meshHeadingpubmed-meshheading:2570359-...lld:pubmed
pubmed-article:2570359pubmed:meshHeadingpubmed-meshheading:2570359-...lld:pubmed
pubmed-article:2570359pubmed:meshHeadingpubmed-meshheading:2570359-...lld:pubmed
pubmed-article:2570359pubmed:meshHeadingpubmed-meshheading:2570359-...lld:pubmed
pubmed-article:2570359pubmed:meshHeadingpubmed-meshheading:2570359-...lld:pubmed
pubmed-article:2570359pubmed:meshHeadingpubmed-meshheading:2570359-...lld:pubmed
pubmed-article:2570359pubmed:meshHeadingpubmed-meshheading:2570359-...lld:pubmed
pubmed-article:2570359pubmed:meshHeadingpubmed-meshheading:2570359-...lld:pubmed
pubmed-article:2570359pubmed:meshHeadingpubmed-meshheading:2570359-...lld:pubmed
pubmed-article:2570359pubmed:year1989lld:pubmed
pubmed-article:2570359pubmed:articleTitleThe inhibition of alpha 1-adrenoceptor-mediated contractions of rabbit pulmonary artery by Ca2+-withdrawal, pertussis toxin and N-ethylmaleimide is dependent on agonist intrinsic efficacy.lld:pubmed
pubmed-article:2570359pubmed:affiliationDepartment of Clinical Pharmacology, Hannover Medical School, Federal Republic of Germany.lld:pubmed
pubmed-article:2570359pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:2570359pubmed:publicationTypeIn Vitrolld:pubmed
pubmed-article:2570359pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2570359lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2570359lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2570359lld:pubmed